A rare case of penile metastases from small cell prostate cancer

Garrido-Abad, Pablo; Rodríguez-Cabello, Miguel Ángel; Vera-Berón, Roberto; Platas-Sancho, Arturo

doi:10.1016/j.androl.2019.11.003

Cited by 2 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Secondary penile tumors are rare and have a poor prognosis, with a mortality rate of 80% within 6 months, 28% of which is accounted for by prostate cancer ( 1 – 3 ). Previous literature has reported that penile metastasis occurs mainly secondary to primary prostate cancer without any medical treatment ( 4 , 5 ) or occurs during an androgen-deprivation therapy (ADT) without surgery ( 6 , 7 ). However, the present case represents a biochemical recurrence of prostate cancer in the penis during ADT after radical prostatectomy with a PSA of 0.072 ng/ml, which has not been reported in the literature so far.…”

Section: Introductionmentioning

confidence: 99%

Case Report: 18F-PSMA-1007 PET/CT Avid Solitary Penile Metastasis of Castration-Resistant Prostate Cancer With a PSA of 0.072 ng/ml

Dong

et al. 2022

Front. Oncol.

View full text Add to dashboard Cite

Penile metastasis of prostate cancer is rare, with a poor prognosis, and only a limited number of relevant cases have been reported so far. With the application of 18F-PSMA-1007 PET/CT, the biochemical recurrence of prostate cancer can be detected at an early stage for providing important evidence, facilitating clinical decision-making. Here, we have reported a case of solitary penile metastatic recurrence in the context of mild PSA progression (PSA: 0.072 ng/ml). This case highlights the preferable sensitivity of 18F-PSMA-1007 PET/CT imaging in prostate cancer.

show abstract